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Objectives: to compare leg blood flow and the long-term cardiovascular prognosis in men with typical and atypical
intermittent claudication (IC) according to Rose's questionnaire.
Methods: leg blood flow during reactive hyperaemia was assessed at 55 years of age by calf plethysmography. Measurement
of the systolic ankle±arm pressure index was used to assess the prevalence of peripheral arterial disease (PAD) at 68 years of
age. Mortality and incidence of cardiac events is based on record linkage with regional and national registers.
Results: twenty-one (3%) out of 700 men had typical IC at 55 years of age. Sixteen (76%) of these had normal
plethysmography, with a mean peak flow (95% CI) of 24.6 (19.3±30.0) ml/min/100 ml. Peak flows were similar and normal
in men with atypical IC (mean 22.5; 95% CI 21.3±23.6) and men having no pain (mean 23.8; 95% CI 23.1±24.4).
Mortality rates were increased in men with typical IC but who had normal leg blood flow (49.5 deaths/1000 person years;
p 0.008), and men having atypical IC (35.3 deaths/1000 person years; p 0.007) in comparison with men having no leg
pain (27.4 deaths/1000 person years). This could not be accounted for by an increased cardiac event rate. The prevalence of
PAD at 68 years of age was not increased in either of these two groups.
Conclusions: only 12% of subjects with exertional pain fulfilled all criteria for typical IC. Typical and atypical claudica-
tion in absence of objective evidence of PAD was associated with a reduced life expectancy, but not with an increased
cardiovascular risk. To properly assess the prognosis, non-invasive assessment of PAD should be used in addition to
questionnaires.
Key Words: Intermittent claudication; Rose's questionnaire; Peripheral arterial disease; Plethysmography; Ankle±arm
index; Myocardial infarction; Mortality.
Introduction
The validity of Rose's questionnaire for intermittent
claudication1 has been assessed in several cross-
sectional studies using non-invasive methods for
evaluation of the peripheral circulation as gold stand-
ard.2±6 According to these studies it seems that not less
than 40±50% of those fulfilling the questionnaire cri-
teria for intermittent claudication have no detectable
impairment of leg blood flow.4,5 Yet in prospective
studies this symptom is associated with increased
cardiovascular morbidity and mortality rates.7±10
Whether this increased risk is true only for the `true
positives' has received little scientific attention.
In cross-sectional studies it is a common experience
that a certain proportion of those who confirm walking-
induced leg pain do not fulfil other criteria required
to establish intermittent claudication.6 The prevalence
and predictive value of atypical intermittent claudica-
tion ± exertional pain that does not force the subject to
stop, or is not relieved within some minutes of rest ±
with regard to the occurrence of cardiovascular dis-
ease has similarly received little scientific attention.
According to two cohort studies it seems that even
these individuals may be exposed to an increased
cardiovascular risk.11,12 Considering the potentially
serious clinical consequences caused by misclassifica-
tion of subjects with leg arteriosclerosis there is a need
of further studies on the prevalence and prognostic
significance of atypical leg pain.
In the population study `Men born in 1914' from
MalmoÈ, symptoms of peripheral arterial disease
(PAD) were assessed by Rose's questionnaire on inter-
mittent claudication at the baseline health examin-
ation at the men's age of 55 in 1968/69.2 The
occurrence of PAD was determined by plethysmo-
graphic assessment of leg arterial blood flow during
reactive hyperaemia. In a new health examination at
68 years of age, segmental systolic blood pressure
measurement was performed.5 The ankle±arm
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pressure index (AAI) is an established non-invasive
technique, and an AAI below 0.9 has been validated
against arteriography in population settings for the
detection also of symptom-free stages of PAD.13±15
The aim of the present follow-up study from this
cohort has been to compare leg blood flow and long-
term rates of mortality and cardiovascular morbidity
in men with typical and atypical intermittent claudi-
cation according to Rose's questionnaire.
Materials and Methods
Study population
The cohort study `` Men born in 1914'', MalmoÈ, Sweden,
was designed to identify determinants for cardiovas-
cular and pulmonary diseases in elderly men.2 All
men born in even months in 1914 and residing in the
city were in 1968/1969, close to their 55th birthday,
invited to a health examination. Seven hundred and
three of 809 invited agreed to participate.
Between 1969 and 1982, 146 (20.8%) of the 703 men
had died and another 92 (13.1%) moved from the city.
The remaining 465 men were in 1982/1983 invited to
a new health examination at their age of 68. Three
hundred and eighty-nine (83.7%) participated in the
investigation, which included segmental leg blood
pressure recording.5
Assessment of symptomatic PAD at
baseline examination
Intermittent claudication (IC) was assessed in 700
(99.6%) of the 703 men, using a Swedish translation
of the WHO/Rose questionnaire.1 Subjects with leg
pain upon walking, where the pain forced them to
stop, and where the pain was relieved within 10 min
of rest, were classified as having typical IC. Subjects
with walking-induced leg pain that did not meet fur-
ther criteria, i.e. the pain did not force them to stop
and/or the pain was not relieved within 10 min of rest,
were classified as having atypical IC.
All men were subject to physical examination,
including inspection of skin with regard to possible
trophic changes; palpation of pulses in the femoral,
popliteal, tibial posterior and dorsalis pedis arteries;
auscultation over the umbilical, inguinal, femoral and
popliteal regions; back status and neurological status.
Calf plethysmography was performed in 684
(97.3%) of the 703 men. Arterial calf blood flow at
rest and during reactive hyperaemia after 3 min of
proximal arterial occlusion was determined with
venous occlusion plethysmography according to the
method described by Dahn.16,17 The flow values were
given in ml/min/100 ml leg volume. The plethysmo-
graphic examination, which has been described exten-
sively previously,2 was carried out at a room
temperature between 23 and 24 C, and performed on
both legs simultaneously with the subject in the
supine position. Proximal arterial occlusion was
achieved by inflation of blood pressure cuffs placed
around the thighs to a suprasystolic pressure level.
The cuff pressure was then rapidly lowered to a level
adequate to occlude the veins only. The following
variables were used in this study: (1) first flow (the
first measured calf blood flow after release of arterial
obstruction); (2) peak flow (the maximum calf blood
flow during reactive hyperaemia); and (3) pulse wave
amplitude (amplitude in mm of pulsation waves
during peak flow). For each variable, the recordings
from both legs were compared and the lowest value
(i.e. that from the worst leg) was chosen for classifica-
tion of individuals.
According to the criteria defined by Fajgelj, subjects
with a pulse wave amplitude 3 mm and first flow
during reactive hyperaemia 14 ml/min/100 ml and
peak flow during reactive hyperaemia 17 ml/min/
100 ml were considered to have PAD.18 All cases with
PAD were angiographically verified, except in one
subject who died shortly after the study and where
the PAD diagnosis was verified at necropsy.2
Risk factors at baseline examination
Smoking habits
Smoking habits were assessed by means of a structured
questionnaire.2 At the examination, the men were
considered to be either current smokers; ex-smokers
(who had quitted at least a month prior to inves-
tigation); or non-smokers. Men with a daily tobacco
consumption of 15 g or more were labelled heavy
smokers.
History of ischaemic heart disease (IHD)
Ischaemic heart disease (IHD) was defined as a his-
tory of myocardial infarction, angina pectoris accord-
ing to the Rose questionnaire,1 or the appearance of a
pathologic Q wave (Minnesota code 1.1, 1.2 or 1.3) on
the resting electrocardiogram.
Hypertension
Systolic and diastolic (phase V) blood pressure was
measured sphygmomanometrically with the subject in
the sitting position after 15 min of rest. Blood pressure
was recorded to the nearest 5 mmHg. Hypertension
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was defined as systolic or diastolic brachial
blood pressure 160/95 mmHg or medication for
hypertension.19
Blood cholesterol
Blood cholesterol levels were analysed by standard
methods and expressed in mmol/l.20
Diabetes mellitus
Diabetes was defined as history of diabetes or pres-
ence of glucosuria as detected by Clinistix.
Ankle±arm blood pressure index (AAI) measurement
at 68 years of age
The recording system consisted of pulse sensors
(mercury-in-Silastic strain gauges) placed on the big
toes and thumbs; two Wheatstone bridges with amp-
lifier to record changes in the resistance of the strain
gauges; blood pressure cuffs (18 cm 60 cm to meas-
ure ankle systolic pressure and 12 cm 35 cm to meas-
ure the upper arm systolic pressure); a pressure
transducer (Siemens-Elema EMT 746 with amplifier
EMT 311) to record cuff pressures; and a six-channel
ink-jet recorder (Siemens-Elema; Mingograph).21±23
Duplicate recordings were made with the subject in
the supine position, and the arithmetic average used.
For each leg, an ankle±arm pressure index (AAI) was
calculated by dividing the ankle systolic pressure with
the highest upper arm systolic pressure value.
Definition of peripheral arterial disease at 68 years of age
Peripheral arterial disease (PAD) at 68 years of age
was defined as an AAI 50.9 in one or both legs.13±15
Subjects with an AAI 0.9 in both legs were consid-
ered free from PAD.
Mortality and morbidity surveillance
Mortality rate
All 703 participants in the 1968/1969 health examin-
ation were followed from this first examination until
their death or until December 31, 1996. Median follow-
up time was 23.3 years (range 0.2±28.1 years). The
follow-up analysis was based on a total of 14 368
person years. Mortality data were obtained from the
Mortality Registry of the Swedish National Bureau of
Statistics. In 60.3% of the deaths, necropsy was per-
formed. Mortality rates were expressed as deaths per
1000 person years of observation. Cases coded 410.0±
412.9 according to the International Classification of
Diseases (ICD) code (8th revised version through
31 December 1986; 9th revised version since 1 January
1987) were counted as deaths from ischaemic heart
disease.
Cardiac event rate
The follow-up period was from the 1968/1969 health
examination until the first cardiac event, death or
December 31, 1996. Median follow-up time was 21.7
years (range 0.1±28.1 years), with a total follow up of
13 657 person years. New cases with myocardial
infarction have been retrieved via the MalmoÈ Heart
Infarction Register.24 A cardiac event was defined as
fatal or nonfatal myocardial infarction (ICD-8 and
ICD-9: code 410.0±410.9) or death from ischaemic
heart disease (ICD-8 and ICD-9: code 410±414).
Statistical methods
Distributions were expressed in terms of mean and
SD. Correlation between risk factors and presence of
confirmed PAD, typical and atypical intermittent clau-
dication (IC) at 55 years of age were analysed using
the Kendall's tau-b test. Survival analysis, using the
Kaplan±Meier method with the generalised Wilcoxon
rank sum test, and Cox's proportional hazards model
for multivariate analysis were used to study mortality
and cardiac event rate in relation to presence of con-
firmed PAD, typical and atypical IC.
Results
Typical and atypical IC in relation to leg blood flow at
55 years of age
Twenty-one (3.0%) out of 700 men had typical inter-
mittent claudication (IC) at 55 years of age (Table 1).
Sixteen (76.2%) of these had normal blood flow during
reactive hyperaemia. Another 146 men (20.9%) had
atypical IC; 145 (99.3%) of these had normal blood
flow. Overall, occlusive PAD was confirmed in 8
(1.1%) of the 703 men, five of which had typical IC,
one atypical IC, one no leg pain and one who had
previously been leg amputated due to PAD and did
not participate in the IC questionnaire or plethysmo-
graphy.2 Hence, the cohort for follow-up in this study
consisted of 701 subjects.
Cardiovascular risk factors at 55 years of age
Across the strata from no leg pain to overt symptom-
atic PAD, it was increasingly more common with a
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history of smoking (p 0.041), with a history of IHD
(p5 0.001) and with hypertension (p 0.080), whereas
blood cholesterol levels were similar (p 0.357)
(Table 2).
Prevalence of PAD at 68 years of age
None of the eight men with confirmed PAD at 55 years
of age participated in the health examination at
68 years of age (Table 3). Of the 16 men who had had
typical IC in absence of blood flow impairment, seven
participated in this second health examination. Only
two of them re-confirmed the presence of IC, and in
none PAD, defined as an ankle±arm pressure index
(AAI) 50.9, was found. Eighty-two (57.9%) of the
men who had had atypical IC at 55 years of age and
300 (59.2%) of the men who had had no leg pain
participated in the second examination of PAD.
Mean AAI and prevalence of AAI50.9 did not differ
between these groups (Table 3).
Twenty-seven year mortality rate
Four hundred and twenty-six (60.8%) of the 701 men
died during the follow-up period between their ages
of 55 and 82. All men with confirmed PAD at their age
of 55 died during follow up, with a resulting mortality
rate of 84.0 deaths/1000 person years, more than three
Table 1. Plethysmographic assessment during reactive hyperaemia in relation to response to Rose's questionnaire on intermittent
claudication (IC) at 55 years of age.
Rose's IC questionnaire
at 55 years of age
N Calf plethysmography at 55 years of age Confirmed
PAD (N, %)
First flow (ml/min/100 ml) Peak flow (ml/min/100 ml) Pulse amplitude (mm)
Mean (95% CI) Mean (95% CI) Mean (95% CI)
Typical IC, all subjects 21 14.8 (11.1±18.4) 19.0 (14.2±23.7) 5.3 (4.1±6.5) 5 (24%)
Typical IC, no PAD 16 17.3 (14.0±20.6) 24.6 (19.3±30.0) 6.3 (5.2±7.3) ±
Atypical IC, all subjects 146 18.6 (17.7±19.5) 22.5 (21.3±23.6) 6.8 (6.5±7.1) 1 (0.7%)
Atypical IC, no PAD 145 18.6 (17.7±19.5) 25.2 (23.9±26.5) 6.8 (6.5±7.1) ±
No leg pain, all subjects 533 19.3 (18.8±19.8) 23.8 (23.1±24.4) 6.7 (6.6±6.9) 1 (0.2%)
No leg pain, no PAD 532 19.3 (18.6±19.8) 26.1 (25.4±26.8) 6.7 (6.6±6.9) ±
Table 2. Cardiovascular risk factors in relation to signs and symptoms of PAD at 55 years of age.
Assessment of PAD
at 55 years of age
N Risk factors at baseline
Smoking habits (N, %) History of
IHD (N, %)
Hypertension
(N, %)
Blood cholesterol
mean (95% C.I.)
Diabetes
mellitus (N, %)
Never
smokers
Ex
smokers
Current
smokers
Heavy
smokers
Confirmed PAD 8 0 (0) 2 (25) 6 (75) 0 (0) 4 (50) 7 (88) 7.1 (5.6±8.7) 1 (13)
Typical IC, no PAD 16 0 (0) 4 (25) 12 (75) 6 (50) 4 (25) 7 (44) 6.4 (6.0±6.8) 1 (6)
Atypical IC, no PAD 145 17 (12) 33 (23) 95 (66) 42 (29) 16 (11) 46 (32) 6.5 (6.3±6.7) 5 (3)
No leg pain, no PAD 532 91 (17) 119 (22) 142 (61) 130 (24) 22 (4) 155 (29) 6.3 (6.2±6.4) 8 (1)
p-Value 0.041 50.001 0.080 0.357 0.098
Heavy smokers defined as a tobacco consumption  15 g/day.
Table 3. Participation, prevalence of intermittent claudication (IC) and ankle±arm pressure index (AAI) 50.9 in either leg at follow-up
examination at 68 years of age in relation to signs and symptoms of PAD at 55 years of age.
Assessment of PAD
at 55 years of age
N Assessment at 68 years of age
Alive at
that time
Participating Prevalence
of IC according
to questionnaire
N (%)
AAI worst
leg mean
(95% C.I.)
AAI 5 0.9 in
either leg N (%)
N (%) N Original
cohort (%)
Men
alive (%)
Confirmed PAD 8 3 (37.5) 0 (0) (0) ± ± ±
Typical IC, no PAD 16 8 (50.0) 7 (43.8) (87.5) 2 (28.6) 1.01 (0.95±1.07) 0 (0)
Atypical IC, no PAD 145 108 (74.5) 82 (57.9) (77.8) 4 (4.9) 1.01 (0.97±1.04) 12 (14.6)
No leg pain, no PAD 532 427 (80.3) 300 (59.2) (73.8) 6 (2.0) 1.00 (0.99±1.02) 43 (14.3)
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times that of men with no symptoms or signs of PAD
(27.4 deaths/1000 person years; p5 0.001) (Table 4,
Fig. 1). Excess mortality rates were also found in
men with typical IC but with normal leg blood flow
(49.5 deaths/1000 person years; p 0.008) and in men
with atypical IC (35.3 deaths/1000 person years;
p 0.007).
Of the eight men with confirmed PAD at age 55, six
died from cardiovascular disease, one from lung can-
cer and one from renal disease. Of the 16 men with
typical IC but normal leg blood flow 13 (81%) died;
four from cardiovascular disease and seven from neo-
plastic disease. The earliest death from cancer in this
group occurred seven years after the assessment of IC.
Among men with atypical IC, 41% of the deaths were
due to cardiovascular disease and 34% from cancer
diseases. The corresponding rates in men who had not
reported of leg pain were 47 and 33%, respectively
(pNS).
The excess total mortality associated with con-
firmed PAD remained after entering smoking, hyper-
tension and previous IHD as risk covariates in a Cox
regression model, with a relative risk of 2.9 (95% C.I. of
1.3±6.1) (Table 5). Corresponding relative risks (95% C.I.)
Table 4. Twenty-seven-year all cause mortality and cardiac event rate in relation to signs and symptoms of PAD at 55 years of age.
Assessment of PAD
at 55 years of age
N All cause mortality rate Cardiac event rate
Follow up
(years)
Deaths Deaths per 1000
person years
p-Value Follow up
(years)
Events Events per 1000
person years
p-Value
N % N %
Confirmed PAD 8 95.19 8 100.0 84.0 50.001 93.53 6 75.0 64.2 50.001
Typical IC, no PAD 16 262.73 13 81.3 49.5 0.008 229.58 4 25.0 17.4 0.423
Atypical IC, no PAD 145 2806.50 99 68.3 35.3 0.007 2698.43 42 29.0 15.6 0.760
No leg pain, no PAD 532 11173 306 57.5 27.4 10609.98 154 28.9 14.5
Reference category.
Table 5. Cox' proportional hazards' model of total mortality and cardiac event rates in relation to signs and symptoms of PAD and
cardiovascular risk factors at 55 years of age.
Risk category Total mortality Cardiac event rate
R.R. (95% C.I.) p-Value R.R. (95% C.I.) p-Value
PAD assessment Confirmed PAD 2.9 (1.3±6.1) 0.007 3.7 (1.6±8.7) 0.003
Typical IC, no PAD 1.6 (0.9±2.8) 0.098 1.1 (0.4±2.9) 0.878
Atypical IC, no PAD 1.3 (1.0±1.6) 0.028 1.0 (0.7±1.4) 0.993
No leg pain, no PAD 1 1
Smoking Current smokers 2.3 (1.7±3.1) 50.001 2.2 (1.4±3.5) 50.001
Ex smokers 1.6 (1.1±2.2) 0.021 1.3 (0.7±2.1) 0.381
Never smokers 1 1
Hypertension Yes vs. no 1.7 (1.4±2.1) 50.001 1.7 (1.3±2.3) 0.001
History of IHD Yes vs. no 1.3 (0.9±1.8) 0.242 2.1 (1.4±3.3) 0.001
Reference category.
Fig. 1. Survival rate during 27-year follow up of 55-year-old men (a)
with no leg pain or confirmed peripheral arterial disease (PAD)
(solid line) (reference group); (b) with atypical intermittent claudi-
cation (IC) but no confirmed PAD (dotted line) (p 0.007); (c) with
typical IC but no confirmed PAD (dashed line) (p 0.008); and (d)
with confirmed PAD (dash-dotted line) (p5 0.001).
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associated with typical IC in presence of normal leg
blood flow and with atypical IC were 1.6 (0.9±2.8) and
1.3 (1.0±1.6), respectively (Table 5).
Twenty-seven year cardiac event rate
Men with confirmed PAD at 55 years of age had more
than four times higher cardiac event rate (64.2 events
per 1000 person years) than men with no leg pain (14.5
events/1000 person years; p5 0.001) (Table 4, Fig. 2).
The excess risk remained when adjusting for smoking,
hypertension and prevalent IHD in the multivariate
analysis (RR 3.7; 95% C.I. 1.6±8.7) (Table 5). In men
with typical IC but no blood flow impairment, or
atypical IC, cardiac event rates did not appear to be
elevated.
Discussion
As in many previous cohort studies, typical intermit-
tent claudication was associated with an increased
incidence of cardiac events and death. However,
among those fulfilling Rose's criteria, not less than
76% had no plethysmographic signs indicating per-
ipheral arterial disease. These men were not exposed
to any excess cardiac risk. Nor could the reduced
survival rate among men having atypical intermittent
claudication be accounted for by an increased inci-
dence of cardiac events.
In most cross-sectional studies of the validity of
Rose's questionnaire on intermittent claudication the
specificity of the method is well above 90%.6 Yet, in
this study population where the prevalence of PAD,
defined as an ankle±arm index below 0.9 was 14% at
68 years of age, the predictive value of a positive
questionnaire was only 56%.5 Among men with typ-
ical intermittent claudication, but whose leg blood
flow was normal at their age of 55, there was, in
comparison with subjects not having leg pain, a
greater proportion who were or had been smokers,
who had history of IHD and/or hypertension. The
lower, albeit non-significant, mean blood flow during
reactive hyperaemia in that group might indicate that
these were risk individuals in an early stage of the
disease and could hence suggest that the occurrence of
leg pain may precede the level of blood flow deteri-
oration that can be detected by plethysmography. This
might be explored in a prospective study as the pre-
sent one. Due to the small number of subjects and the
over-representation of risk individuals for peripheral
arterial disease among those who died during the
follow up between 55 and 68 years of age, i.e. smokers
and subjects with hypertension, this is not possible to
evaluate in the present study.
It should be noted that five of the seven men, who
had typical intermittent claudication at 55 years of
age, despite a normal leg blood flow, no longer had
symptoms at 68 years of age and none of the seven
men had a systolic ankle±arm index below 0.9. Fur-
thermore, the increased total mortality rate among
men with typical intermittent claudication but whose
leg blood flow was normal could in this study not be
accounted for by an increased cardiovascular morbidity.
It remains to be evaluated to what extent the reduced
life expectancy in that group is due to an over-
representation of other survival-reducing conditions,
i.e. mental disorders, respiratory diseases, cancer.
Whereas typical intermittent claudication is clearly
explainable as an ischaemic leg pain that develops
upon exertion and is relieved after a moment of
rest,6 the nature of atypical intermittent claudication
has not been elucidated. The observation by some of
an increased cardiovascular mortality rate associated
with this condition has led to the suggestion that
atypical intermittent claudication is indeed another
symptom of PAD.11,12 Since it is clear from population
studies using non-invasive techniques that the preva-
lence of PAD is higher than that of typical intermittent
claudication, and that Rose's questionnaire has a rela-
tively low sensitivity for the detection of PAD,6 this
would not be an unreasonable hypothesis. The finding
in two recent cross-sectional studies, of an increased
odds rate for low ankle±arm index in individuals with
Fig. 2. Cardiac event-free survival rate during 27-year follow up of
55-year-old men (a) with no leg pain or confirmed peripheral arter-
ial disease (PAD) (solid line) (reference group); (b) with atypical
intermittent claudication (IC) but no confirmed PAD (dotted line)
(p 0.760); (c) with typical IC but no confirmed PAD (dashed
line) (p 0.423); and (d) with confirmed PAD (dash-dotted line)
(p5 0.001).
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atypical exertional leg pain, indicates that this may be
explained by PAD in some cases.25,26
The prevalence of atypical intermittent claudication
was 20.6%, seven times that of typical intermittent
claudication. No evidence was found supporting the
assumption that even atypical IC could be a symptom
of peripheral arterial disease. Blood flow and pulse
wave amplitudes during reactive hyperaemia in that
group did not differ from the average blood flow and
pulse wave amplitudes among men having no leg pain.
The average systolic ankle±arm index at 68 years of
age did not differ between these two groups and the
prevalence of pressure indices below 0.9 was very
similar. Furthermore, atypical IC was not associated
with an increased incidence of cardiac events; yet it
was a symptom associated with reduced life expect-
ancy. The reason for that can only be speculated upon.
Thirteen years after the health examination at
55 years of age 22% of the men were no longer alive.
Almost half of these premature deaths were due to
cardiovascular diseases. The increased risk associated
with exposure to smoking, high blood pressure and
high blood lipid levels has been documented in a
number of prospective studies.27±30 As many of those
being exposed to these risk factors even in long term
studies remain alive and healthy it is obvious that
between individuals there are great differences in vul-
nerability. In this context, intermittent claudication, a
condition of dire prognostic significance,7±10 can and
should be considered a marker of vulnerability in the
assessment of subjects exposed to risk factors asso-
ciated with cardiovascular disease. In order to
improve the cost-effectiveness of treatment and pre-
vention there is a need of studies that can improve our
understanding of who will benefit the most.
It is our conclusion from this study that although
Rose's questionnaire for intermittent claudication has
a high specificity, the predictive value of a positive test
is low. Only 12% of those who had leg pain on exercise
fulfilled all criteria for intermittent claudication. Sub-
jects having typical or atypical claudication but with
no objective evidence of PAD had a reduced life
expectancy, but this was not associated with an
increased cardiovascular risk. To properly assess the
prognosis, non-invasive assessment of PAD should be
used in addition to questionnaires.
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Appendix
Rose's Questionnaire on Intermittent Claudication
If an answer is recorded in a box marked , no further
questions need be asked
1. Do you get pain in either leg on walking?
Yes [ ]
No []
2. Does this pain ever begin when you are standing
still or sitting?
Yes []
No [ ]
3. In what part of your leg do you feel it?
Pain includes calf/calves [ ]
Pain does not include calf/calves []
If calves not mentioned, ask: Anywhere else?
4. Do you get it if you walk uphill or hurry?
Yes [ ]
No []
Never hurries or walks uphill [ ]
5. Do you get it if you walk at an ordinary pace on the
level?
Yes [ ]
No [ ]
6. Does the pain ever disappear while you are walk-
ing?
Yes []
No [ ]
7. What do you do if you get it when you are walk-
ing?
Stop or slow down [ ]
Carry on []
8. What happens to it if you stand still?
Relieved [ ]
Not relieved [ ]
9. How soon?
10 min or less [ ]
More than 10 min [ ]
`` Intermittent claudication'' is defined as being pre-
sent in subjects who answers as follows:
Q1: `` Yes''; Q2: `` No''; Q3: `` Includes calf''; Q4 or Q5:
`` Yes''; Q6: `` No''; Q7: `` Stop or slow down''; Q8:
`` Relieved''; Q9: `` 10 min or less''.
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